Praiseworthiness and Motivational Enhancement: 'No Pain, No Praise'?
achievement
commitment
effort
motivational enhancement
praiseworthiness
Journal
Australasian journal of philosophy
ISSN: 0004-8402
Titre abrégé: Australas J Philos
Pays: Australia
ID NLM: 100972330
Informations de publication
Date de publication:
2020
2020
Historique:
received:
04
02
2018
revised:
12
02
2019
entrez:
16
6
2020
pubmed:
17
6
2020
medline:
17
6
2020
Statut:
epublish
Résumé
The view that exertion of effort determines praiseworthiness for an achievement is implicit in 'no pain, no praise'-style objections to biomedical enhancement. On such views, if enhancements were to reduce the need for effort, agents would be less praiseworthy. Motivational enhancement would appear to be the most problematic in this respect, given that increased motivation reduces the need for agents to rally themselves and to exert effort in activity. We use the prospect of motivational enhancement to re-examine the grounds of praiseworthiness for achievements. We consider the place of effort amongst the grounds for praise, whether effort exhausts these grounds, and how they can be better specified. We argue that praiseworthiness depends on (i) the voluntariness and strength of the agent's committed pursuit of a valuable end (E), (ii) the costliness of the committed pursuit of E, and (iii) the value of E. Effort is just one cost amongst many, and costs of activities can be traded-off. Motivational enhancement reduces the praise due to an agent only when it reduces the net cost to the agent (without strengthening the voluntary commitment). We emphasize the importance of a diachronic perspective on active agency for praiseworthiness, to include training, prior planning, and deliberate strategies to overcome weakness of will, even where this reduces the need for effort.
Identifiants
pubmed: 32539023
doi: 10.1080/00048402.2019.1618883
pii: 1618883
pmc: PMC7254567
doi:
Types de publication
Journal Article
Langues
eng
Pagination
304-318Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 104848
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 104848/Z/14/Z
Pays : United Kingdom
Informations de copyright
© 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Références
Neuron. 2013 Jul 24;79(2):391-401
pubmed: 23889938
Br J Clin Pharmacol. 2008 Jun;65(6):833-40
pubmed: 18341680
Front Neurosci. 2013 Oct 31;7:198
pubmed: 24198755
Neuroscience. 2016 Dec 17;339:363-375
pubmed: 27751960
J Neurosci. 2011 Nov 16;31(46):16597-602
pubmed: 22090487
Psychol Sci. 2011 Apr;22(4):498-506
pubmed: 21378368
Kennedy Inst Ethics J. 2010 Jun;20(2):145-60
pubmed: 20653250
J Strength Cond Res. 2008 Mar;22(2):464-70
pubmed: 18550961
Neuropsychopharmacology. 2011 Jan;36(1):133-52
pubmed: 20631684
New Atlantis. 2003 Spring;(1):9-28
pubmed: 15584192
Psychopharmacology (Berl). 2004 Dec;177(1-2):161-9
pubmed: 15221200
Contemp Educ Psychol. 2000 Jan;25(1):54-67
pubmed: 10620381
Bioethics. 2008 Aug;22(7):355-63
pubmed: 18445089
Front Syst Neurosci. 2014 Jun 11;8:107
pubmed: 24999320